Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat  by Park, Hyun-Joo et al.
1773 (2007) 1462–1472
www.elsevier.com/locate/bbamcrBiochimica et Biophysica ActaUp-regulation of VEGF expression by NGF that enhances reparative
angiogenesis during thymic regeneration in adult rat
Hyun-Joo Park a,d, Mi Na Kim a, Jong-Gab Kim a,d, Yun-Hee Bae a,d,
Moon-Kyoung Bae b, Hee-Jun Wee c, Tae-Woo Kim a, Bong-Seon Kim a,
Jae-Bong Kim a, Soo-Kyung Bae a,d,⁎, Sik Yoon a,d,⁎
a Department of Anatomy, School of Medicine, Pusan National University, Busan, 602-739, South Korea
b Department of Oral Physiology, School of Dentistry, Pusan National University, Busan, 602-739, South Korea
c Department of Biochemistry, School of Medicine, Institute for Tumor Research, Chungbuk National University, Cheongju, 361-763, South Korea
d Medical Research Center for Ischemic Tissue Regeneration, Pusan National University, Busan, 602-739, South Korea
Received 31 January 2007; received in revised form 7 May 2007; accepted 8 May 2007
Available online 21 May 2007Abstract
Angiogenesis is important for adult tissue regeneration as well as normal development. Vascular endothelial growth factor (VEGF) is a unique
potent angiogenic factor, and plays an essential role in regulating angiogenesis during embryonic development, normal tissue growth, and tissue
regeneration. Recent evidence shows that nerve growth factor (NGF) also plays a role as an angiogenic regulator as well as a well-known
neurotrophic factor. The aim of this study was to investigate whether thymus regeneration accompanies reparative angiogenesis and also to evaluate
whether the thymic expression of VEGF is regulated by NGF in vivo and in vitro. Here, we show that high VEGF mRNA and protein levels are
concomitant with reparative angiogenesis that occurs dramatically during regeneration following acute involution induced by cyclophosphamide
(CY) in the rat thymus. Fluorescent thymus angiography using FITC-dextran showed that thymic regeneration is associated with a much denser
capillary network compared with normal control thymus. Furthermore, the expressions of NGF and TrkA were highly increased during thymic
regeneration. We also show that NGF mediates thymic epithelial induction of VEGF expression in vitro and in vivo. Taken together, our results
suggest that NGF-mediated VEGF up-regulation in thymic epithelial cells may contribute to reparative angiogenesis during thymic regeneration in
adult.
© 2007 Elsevier B.V. All rights reserved.Keywords: Angiogenesis; Thymic Regeneration; Thymic Epithelial Cell; VEGF; NGF1. Introduction
Angiogenesis, the formation of new capillary blood vessels
from existent microvessels [1], is critical for normal embryonic
development and also contributes many pathological states
including tumor growth [2,3]. In addition, angiogenesis is es-
sential for tissue regeneration in adults [4,5]. In the physiolo-
gical condition, the activity of inducers and inhibitors of
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doi:10.1016/j.bbamcr.2007.05.006Vascular endothelial growth factor (VEGF), a highly specific
mitogen for vascular endothelial cells, regulates vasculogenesis,
angiogenesis, and vascular maintenance during embryogenesis
and in adults [3,7–9]. VEGF binds to three receptor tyrosine
kinases (RTKs), known as VEGF receptor-1 (Flt-1), -2 (KDR)
and -3 (Flt-4), as well as to the neuropilin-1 and neuropilin-2 co-
receptors [10]. The binding of VEGF to the receptors induces
receptor dimerization and activation, resulting in the prolifera-
tion and growth of endothelial cells [11]. VEGF expression is
up-regulated by hypoxia [12] or by different cytokines and
growth factors even in normoxia [13–15]. Recent evidence
shows that nerve growth factor (NGF) is able to induce the
expression of VEGF in neuronal tissue [16] and in tumor [17].
NGF, a well-known neurotrophin in the nervous system
[18], has been recently described as an ‘angiogenic’ molecule
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and migration [20,21], or indirectly by increasing VEGF gene
expression [22,23]. NGF forms covalent homodimers that
activate two types of receptor, the TrkA (tropomyosin-receptor
kinase A) and p75NTR receptors [24,25]. Our recent studies
have demonstrated that the expressions of NGF and TrkA re-
ceptor were up-regulated in the thymic epithelial cells during
rat thymic regeneration following cyclophosphomide-induced
acute involution [26,27]. However, the role of NGF/TrkA
signaling in the process of thymic regeneration remains to be
established.
Thymus has a central role in the immune system and
harbors an organ-typical dense network of branching and
anastomosing blood vessels [28,29]. It has been well
documented that acute thymic involution, induced in experi-
mental animals, is followed by intensive regeneration after the
removal of the causative stimuli [30]. Although recent studies
regarding the roles of angiogenesis in stimulating adult tissue
regeneration have been published [4,5,31], they do not much
address the molecular basis of the reparative angiogenesis
during adult tissue repair/regeneration, especially in the thymic
regeneration.
The purpose of this study was to examine whether reparative
angiogenesis is accompanied by adult thymic regeneration and
to investigate the expression patterns of VEGF and its regu-
lation by NGF signaling in thymic epithelial cells. We examined
blood vessel network and VEGF expression in regenerating
thymus. We next studied the effect of NGF on in vivo VEGF
expression and thymic vascularization, and its effect on in vitro
VEGF expression.
2. Materials and methods
2.1. Reagents and antibodies
Rabbit polyclonal anti-human VEGF and mouse monoclonal anti-human
VEGF antibodies were purchased from Santa Cruz Biotechnology and Upstate,
respectively. Mouse monoclonal anti-rat CD31 (PECAM-1) and rabbit poly-
clonal anti-human vonWillibrand Factor (vWF) antibodies were purchased from
BD Pharmingen and Chemicon, respectively. Goat polyclonal anti-human TrkA
and rabbit polyclonal anti-human TrkA antibodies were purchased from Santa
Cruz Biotechnology. Mouse monoclonal anti-human Cytokeratin antibody was
purchased from Dako Ltd. Biotin-conjugated donkey anti-mouse IgG and
biotin-conjugated donkey anti-rabbit IgG antibodies were purchased from
Jackson ImmunoResearch Laboratories, Inc. Fluroescein (FITC)-conjugated
donkey anti-rabbit IgG and Texas Red dye-conjugated donkey anti-mouse IgG
antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc.
FITC-dextran and K-252a were purchased from Sigma and Calbiochem,
respectively. NGF was purchased from R&D system.
2.2. Experimental acute thymic involution and regeneration model
Adult male specific pathogen-free Sprague–Dawley rats were purchased
from Dae Han Bio Link (Seoul, Korea). All rats were housed three to four per
cage and maintained under a 12-h light/dark cycle at 24 °C in a specific patho-
gen-free and humidity-controlled facility. Animals were provided with standard
sterile food and water ad libitum, and were allowed to adjust to their environ-
ment for 1 week. Animals were used at 8–10 weeks of age, by being given a
single intraperitoneal dose of cyclophosphamide (150 mg/kg body weight,
Sigma) in normal saline [26,30], and were sacrificed in group of four at 3, 7 and
14 days after injection. Rats given the same amount of normal saline were usedas controls. Three independent experiments were performed, with 16 animals
in each experiment (four animals in each group). Animal care and all experi-
mental procedures were conducted in accordance with the ‘‘Guide for Animal
Experiments’’ edited by the Korean Academy of Medical Sciences.
2.3. Angiography
To visualize blood vessels by whole-mount fluorescence microscopy, the
rats were injected i.v. with 2×106 molecular weight FITC-dextran (50 mg/ml,
Sigma) [32]. Ten minutes after the injection, rats were sacrificed. For
cryosections, the thymus was removed and rapidly frozen in isopentane cooled
with liquid nitrogen. Frozen sections (30 μm thick) were cut on a Reichert
cryostat and placed on 3-aminopropyltriethoxysilane-coated slides. The samples
were examined under a fluorescence microscope (Axiphot, Zeiss, Oberkochen,
Germany).
2.4. Immunohistochemistry
After cryosections, immunostaining was performed by using the streptavidin–
biotin complex (ABC) method. In brief, the sections were incubated for 20 min
in a solution of phosphate-buffered saline (PBS) containing 0.3% H2O2 to
eliminate endogenous peroxidases. After washing in PBS, the sections were
incubated with 3% BSA (BSA, Sigma). The excess solution was shaken off and
the sections were incubated for 16–18 h at 4 °C with a rabbit polyclonal anti-
VEGF antibody, diluted 1:100 (Santa Cruz), or with a mouse monoclonal anti-
CD31 (PECAM-1) antibody, diluted 1:200 (BD bioscience). Following
incubation with the primary antibody, the sections were washed three times
for 5 min with PBS and incubated for 1 h at room temperature with goat anti-
rabbit biotinylated antibody diluted 1:100 (Jackson ImmunoResearch Labora-
tories) or with donky anti-mouse biotinylated antibody diluted 1:100 (Jackson
ImmunoResearch Laboratories). They were then rinsed in PBS and incubated
for 60 min at room temperature with an ABC reagent (Vectastain Elite Kit;
Vector Laboratories) according to the manufacturer's instructions. The sections
were developed in 0.05% 3, 3′-diaminobenzidine and 0.003% H2O2 medium
under microscopic control at room temperature to visualize peroxidase activity.
Light microscopy slides were observed and photographed using an Olympus
BX50 microscope. All photomicrographs were taken with an Olympus C-3030
digital camera.
2.5. Immunocytochemistry
Cells cultured on a coverglass were fixed in 10% paraformaldehyde (in
phosphate buffered saline) for 10 min, blocked with 0.3% Triton X-100/10%
fetal bovine serum/PBS for 1 h, and then labeled with appropriate primary
antibodies. After overnight incubation at 4 °C, the cells were washed with cold-
PBS three times and incubated with FITC- conjugated secondary antibodies for
1 h at RT. Coverslips were mounted in Vectastain containing DAPI (Vector
Laboratories). Cells were analyzed using fluorescent microscope (Axiphot,
Zeiss, Oberkochen, Germany).
2.6. Western blot
Samples (30 μg total protein/lane) were dissolved with loading buffer (0.1 M
Tris–HCl buffer pH 6.8, containing 0.2 M DTT, 4% SDS, 20% glycerol, and
0.1% bromophenol blue), separated by 12% SDS-PAGE, and electrophoretically
transferred to nitrocellulose membrane (Amersham-Pharmacia Biotech) by
semidry transfer (Bio-Rad). The membranes were incubated for 40 min at room
temperature with blocking buffer (10% skim milk, 10 mM TRIS pH 7.5,
100 mM NaCl, 0.1% Tween 20). Membranes were washed three times for
10 min each at room temperature in TTBS (10 mM Tris pH 7.5, 100 mM NaCl,
0.1% Tween 20) followed by an incubation for 1 h at room temperature with
rabbit anti-VEGF or with mouse anti-β-actin. Membranes were washed three
times for 10 min each at room temperature in TTBS and incubated for 1 h with
horseradish peroxidase-conjugated anti-rabbit IgG as the secondary antibody.
The blots were developed with ECL (Amersham Pharmacia Biotech) as the
chromophore.
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analysis
Total RNA was isolated from each sample using Trizol RNA Extraction
Reagent (Bio Rad) following the manufacturer's protocol. First-strand cDNA
synthesis was carried out on 2 μg of total RNA with a reverse transcription kit
(Invitrogen). One-tenth of the reaction mixture was used as template for PCR
amplification. The PCR reaction condition and the sequences of primers are
available upon request. After the PCR, the amplified products were analyzed by
electrophoresis in 1.5% agarose gel and visualized by ethidium bromide staining
under UV light illumination. Band intensities of the PCR products were
measured using an image analysis program (MetaMorph, Universal Imaging
Corporation). Data were expressed as ratios of each mRNA normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAwhich was used
for internal control.Fig. 1. Increased angiogenesis during thymic regeneration. (A) Photographs of thym
(left). Quantitative analysis of thymus weights measured at 3, 7, 14 days after CY t
induced a marked decrease in thymus weights. On day 3 the thymic weight was 85
started to recover. On day 14 the thymus weights were 420±1.9 mg. (B) Blood vesse
and 14 (CY14d) days after CY treatment was determined by fluorescent angiograph
normal thymus (a–c) and regenerating thymus at 3 (d–f), 7 (g–i) and 14 (j–l) d
Interlobular septum. Magnification is 200×.2.8. Cell line and culture
Thymic subcapsular/cortex epithelial cell (427.1; SNEC) line was kind gift
of Dr. Barbara B. Knowles (The Jackson Laboratory). The cells were cultured in
Dulbecco's modified Eagle medium (Gibco-BRL) supplemented with 10% Fetal
bovine serum, 100 units/ml penicillin and 100 μg/ml streptomycin at 37 °C in a
humidified incubator with 5% CO2 in 95% air. Compound K252a (100 nM,
Sigma), a tyrosine-kinase inhibitor, was used to study involvement of the TrkA
receptor. Cells were pre-treated with K252a or its solvent for 1 h before NGF
(Allomon) treatment.
2.9. In vivo NGF injection
Mice were used at 8–10 weeks of age, by being given a single intraperitoneal
dose of cyclophosphamide (450 mg/kg body weight, Sigma) in normal saline. Sixus showing regeneration after cyclophosphamide (CY) treatment at 150 mg/kg
reatment. The mean weight of normal thymus was 610±4.5 mg. CY treatment
±1.0 mg. On day 7 the thymic weight was 105±1.2 mg. From then the thymus
l density in normal thymus (N) and regenerating thymus at 3 (CY3d), 7 (CY7d),
y using FITC-dextran. Magnification is 200×. (C) Expression of PECAM in the
ays after CY treatment was determined by immunohistochemical staining. IS
Fig. 1 (continued).
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(Allomon). Another control group received intraperitoneally injection of saline
solution. Mice were sacrificed in group of four at 2 and 5 days after NGF injec-
tion, respectively. For cryosections, the thymus was removed and rapidly frozen
in isopentane cooled with liquid nitrogen. Frozen sections (5 μm thick) were
cut on a Reichert cryostat and placed on 3-aminopropyltriethoxysilane-coated
slides.
3. Results
3.1. Thymic regeneration accompanies reparative
angiogenesis
Thymus regenerates to its normal mass within 14 days after
acute involution induced by cyclophosphamide (CY) in the rat
(Fig. 1A). To investigate whether the thymic regeneration ac-
companies reparative angiogenesis, fluorescein isothiocyanate-
dextran (FITC-dextran) was used for angiography. The FITC-
dextran angiography revealed that thymic blood vessel density
was significantly elevated at 3 days after CY treatment, andlevels peaked at this time point and then declined by 14 days
(Fig. 1B), an observation confirmed by immunostaining for
PECAM-1 (Fig. 1C). Similar results were obtained by
immunostaining for von-Willebrand factor (data not shown).
3.2. Upregulation of VEGF, TrkA and NGF expressions during
thymic regeneration
A number of proteins have been reported to be induced
during angiogenesis [1,2]. These include VEGF, a well-known
potent angiogenic factor [7,8]. Since angiogenesis was dra-
matically induced during thymic regeneration (Fig. 1), we exa-
mined the expression pattern of VEGF in regenerating thymus.
Immunostaining for VEGF protein revealed that the levels of
VEGF protein were highest at 3 days after CY treatment (Fig.
2A: c and d) and then decreased gradually to basal level by 14
days (Fig. 2A: e to h). To assess whether the changes of VEGF
protein levels in the regenerating thymus were due to a local
production of the VEGF, we measured the levels of VEGF
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VEGF mRNAs were markedly increased at 3 days after CY
treatment by ∼7.3-fold over the normal control. Furthermore,Fig. 2. Up-regulation of VEGF, TrkA and NGF expressions during thymic regenerati
medulla (b, d, f, h) of the normal thymus (a–b) and regenerating thymus at 3 (c–d), 7
(100X). (B) RT-PCR analysis showing mRNA levels of VEGF, TrkA, NGF, and Fox
CY treatment (left). Relative VEGF, TrkA, and NGF mRNA levels normalized wi
independent experiments was quantified by scanning densitometry and then expressconsistent with previous data [26,27], the increase in TrkA
mRNA level was apparent throughout the time course, with
peak expression at 3 days (∼2-fold elevation over control)on. (A) Immunohistochemical localization of VEGF in the cortex (a, c, e, g) and
(e–f) and 14 (g–h) days after CY treatment. Magnification is 200×. Inner panel
N1 in the normal thymus (N) and regenerating thymus at 3, 7, and 14 days after
th GAPDH mRNA (right). The density of each band in each lane from three
ed as mean±SD.
Fig. 2 (continued).
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NGF, which acts as a TrkA ligand, was elevated in the rege-
nerating thymus at 3 days after CY treatment and then gradually
declined by 14 days (Fig. 2B). To investigate the possibility that
the upregulation of VEGF, TrkA, and NGF may be due to thy-
mus composition (e.g. more TEC and less thymocytes), we
checked the expression pattern of FoxN1, which is specifically
expressed in thymic epithelial cells in thymus [33], and found
that the levels of FoxN1 mRNAwas unchanged during thymic
regeneration (Fig. 2B). Therefore, the upregulation of VEGF,
TrkA and NGF mRNA expression is likely due to the increased
expression in thymic epithelial cells (TEC) rather than changes
in thymic cellular composition.
3.3. Co-localization of VEGF in TrkA-positive thymic epithelial
cells (TECs)
We next examined what types of cells are responsible for the
VEGF expression. Double-immunohistochemistry for VEGF
and cytokeratin (CK) revealed that strong VEGF signals were
detected in the thymic epithelial cells displaying immunor-
eactivity for CK during thymic regeneration (Fig. 3: a to c).
Consistent with previous data [28], the enhanced levels of TrkA
protein were observed in cytokeratin (CK)-positive thymic
epithelial cells of the regenerating thymus (data not shown).
Since both VEGF and TrkA proteins were observed in thymicepithelial cells, we evaluated whether VEGF and TrkA proteins
were expressed in the same epithelial cells. The VEGF and
TrkA proteins were co-localized in CK-positive thymic epi-
thelial cells (Fig. 3: d to f), although there were some cells
positive for TrkA and negative for VEGF and vice versa.
3.4. Up-regulation of VEGF and vWF expression by NGF in vivo
Since NGF/TrkA signaling affects VEGF gene expression in
endothelial cells [21,23], we investigated whether the enhanced
NGF/TrkA signaling in regenerating thymus can up-regulate the
VEGF expression in thymus. Intraperitoneal injection of NGF
after CY treatment significantly elevated the VEGF protein
levels in the thymus (Fig. 4c, f, and i), compared with PBS-
injected (Fig. 4b, e, and h) or normal control (Fig. 4a, d, and g)
thymus. We next examined the effects of NGF-mediated VEGF
upregulation on stimulating reparative angiogenesis in thymus.
Immunostaining for vWF protein, one of vascular markers,
revealed that the thymic blood vessel density was highly ele-
vated in NGF-injected thymus (Fig. 4l), compared with PBS-
injected (Fig. 4k) or normal control (Fig. 4j) thymus.
3.5. Up-regulation of VEGF expression by NGF in vitro
Since cells immunolabeled for both TrkA receptor and VEGF
were identifiable as thymic epithelial cells (Fig. 3), we used thymic
Fig. 3. Co-localization of VEGF in TrkA-positive thymic epithelial cells. Two-color, double labeled immunofluorescent staining of TrkA, VEGF and pancytokeratin
(CK) on thymic epithelial cells in rat thymus at 3 days after CY treatment. The individual recordings were used to create the merged images (c, f) showing simultaneous
detection of VEGF and pancytokeratin (a, b), or VEGF and TrkA (d, e). Arrows indicate the thymic paraseptal epithelial cells. C cortex. Magnification is 200×.
1468 H.-J. Park et al. / Biochimica et Biophysica Acta 1773 (2007) 1462–1472subcapsular/cortex epithelial cell line, SNEC, to confirm the in
vivo stimulating effects of NGF onVEGFgene expression in vitro.
TrkA transcripts were detected in SNEC (data not shown),
suggesting that NGF can trigger intracellular signals to activate the
expression of target genes in SNEC. As shown in Fig. 5A, NGF
increased VEGFmRNA levels in SNEC by∼2.5-fold. The levels
ofVEGFproteinwere also elevated under the treatment ofNGFby
∼4.0-fold (Fig. 5B). The findings from Western immunoblot
analysis were further corroborated by immunocytochemistry. As
shown in Fig. 5C, the VEGF signal was stronger in NGF-treated
cells than in the untreated cells. These results strongly suggested
that NGF could function as an upstream signal for activating
VEGF gene expression in thymic epithelial cells.
To demonstrate that NGF-mediated VEGF gene induction is
a specific receptor-mediated event, we used a selective anta-
gonist of TrkA, K252a. As shown in Fig. 5D, K252a at a
nontoxic and selective concentration of 100 nM prevented NGF
induction of VEGF gene expression, indicating that the effect of
NGF on VEGF gene induction is specifically TrkA-mediated.
4. Discussion
The present results showed that reparative angiogenesis
occurs during adult thymic regeneration. Thymic blood vessel
density examined by both angiography (Fig. 1B) and PECAM
staining (Fig. 1C) was significantly elevated at 3 days after CY
treatment, when thymic regeneration begins to occur (Fig. 1A).
Therefore, the thymus might be a good model system for
studying the molecular basis of reparative angiogenesis that is
closely associated with adult tissue regeneration.Angiogenesis is essential for normal embryonic development
and also contributes many pathological states such as tumor
growth [1–3,6]. Although recent studies regarding important
roles of angiogenesis in stimulating adult tissue regeneration
have been published [4,5], they do not much address the
molecular basis of the reparative angiogenesis during adult tissue
repair/regeneration. Recent studies reported that therapeutic
angiogenesis stimulated by angiogenic factors is important for
ischemic tissue regeneration [34]. Therefore, considering that
enhanced reparative angiogenesis accompanies thymic re-
generation (Fig. 1), it is likely that the levels of angiogenic
factor(s) may be elevated in regenerating thymus. Many angio-
genic factors have been known to control blood vessel formation
[1–3,6]. Among them, VEGF is a crucial mediator of vascular
hyperpermeability, angiogenesis, and inflammation, processes
intimately involved in tissue repair/regeneration [4,5,
7,8,31,34,35]. In this study, the dramatic increase of VEGF
protein (Fig. 2A) and mRNA (Fig. 2B) was found in the rege-
nerating thymus at 3 days after CY treatment, which is con-
current with the higher density of microvessels (Fig. 1B and C).
The strong correlation between up-regulated expression of
VEGF and microvessel density suggests that reparative angio-
genesis in regenerating thymus might be, at least in part, de-
pendent on VEGF induction.
Neurotrophins (NTs) are a family of secreted growth factors
consisting of nerve growth factor (NGF), brain-derived neuro-
trophic factor (BDNF), neurotrophin-3 (NT-3), and neurotro-
phin-4/5 (NT-4/5) [36]. In the thymus, mRNAs for all
neurotrophins and their receptors have been detected. The
recent studies strongly indicate that NTs control the biology of
Fig. 4. Up-regulation of VEGF and vWF expression by NGF injection in vivo. Immunohistochemical staining of VEGF (brown) in thymus from the normal mice
(a, d, g), and PBS-injected (b, e, h) or NGF-injected mice at 5 days after CY treatment (c, f, i). Immunohistochemical staining of vWF (green) in the normal mice
(j), and PBS-injected (k) or NGF-injected (l) mice from 5 days after CY treatment. C cortex, M medulla. Magnification is 200×.
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survival, and are involved in the thymic organogenesis [37].
It has been shown that the thymic TrkA is necessary in
normal thymogenesis [38] and NGF administration produces
epithelial cell hypertrophy in vivo [39] and increases the trans-
cription of IL-6, an important mediator of T cell development
within the thymus, in epithelial cells in vitro [40].
We have recently demonstrated the up-regulated expression
of NGF [27] and TrkA [26] in predominantly thymic epithelial
cells during thymic regeneration from acute involution induced
by cyclophosphamide in the rat. The presence of NGF but also
its upregulated expression was mainly observed in the sub-
capsular, paraseptal, and perivascular epithelial cells, and me-
dullary epithelial cells including Hassall's corpuscles in both
the normal and regenerating thymus [27]. In the case of TrkA,
its expression was found in the subcapsular, paraseptal, perivas-
cular, and medullary epithelial cells in the normal rat thymus.
Cortical epithelial cells show very faint or almost no staining.Significantly increased expression of TrkA protein is observed
in thymic epithelial cells, primarily in subcapsular, paraseptal,
perivascular, and cortical epithelial cells during thymus rege-
neration following cyclophosphamide-induced acute involution
[26]. Also, during corticoid-induced thymic degeneration the
cortical epithelial cells that normally lack TrkA express this
receptor [41]. These findings indicate that the TrkA receptors on
the thymic epithelial cells in the cortex may be more involved in
the regenerative mechanisms of the rat thymus resulting from
acute involution than the TrkA receptors on the medullary
epithelial cells. However, the contribution made by the NGF–
TrkA interaction to thymic regeneration remains to be defined.
Since NGF plays a role as an angiogenic factor [16,17,19–
23,42,43], it is conceivable that enhanced NGF/TrkA signaling
may be responsible for stimulating reparative angiogenesis du-
ring thymic regeneration. Interestingly, VEGF protein was co-
localized in the TrkA-positive thymic epithelial cells (Fig. 3: d
to f), indicating a link between NGF/TrkA signaling and VEGF
Fig. 5. Up-regulation of VEGF expression by NGF treatment in vitro. (A) RT-PCR analysis showing mRNA levels of VEGF in mouse thymic subcapsular/nurse
epithelial cells (SNEC) (left). The cells were incubated for 6, 12, 24 and 48 h after NGF treatment (100 ng/ml). Relative VEGF mRNA levels normalized with
GAPDH mRNA (right). The density of each band in each lane from three independent experiments was quantified by scanning densitometry and then expressed
as mean±SD. (B) Western blot analysis of VEGF protein expression in the SNEC (left). The cells were incubated for 12, 24 and 48 h after treatment with NGF
(100 ng/ml). α-Tubulin was used as a control protein. Relative GFAP protein levels normalized with α-Tubulin protein (right). The density of each band in each
lane from three independent experiments was quantified by scanning densitometry and then expressed as mean±SD. (C) Photographs showing indirect
immunofluorescence analysis of SNEC either untreated (–) or treated with NGF (100 ng/ml) for 24 h, then immunocytochemically stained with rabbit polyclonal
anti-human VEGF antibody. The signal was detected with fluorescent conjugated secondary antibody, FITC-conjugated goat anti-rabbit IgG (green). Nuclei were
stained with DAPI (blue). (D) RT-PCR analysis showing mRNA levels of VEGF in SNEC treated with K252a, a TrkA inhibitor (top). The cells were pretreated with
K252a (100 nM) for 1 h and then incubated for 12 h under the treatment of NGF (100 ng/ml). Relative VEGF mRNA levels normalized with GAPDH mRNA
(bottom). The density of each band in each lane from three independent experiments was quantified by scanning densitometry and then expressed as mean±SD.
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in addition to direct proliferating effects on endothelial cells,
NGF exhibits its angiogenic activity by modulating VEGF gene
expression via TrkA receptor [17,19,23]. To investigate whether
NGF/TrkA signaling system directly controls VEGF gene
expression in thymic epithelial cells, we used thymic epithelial
cell line, SNEC (subcapsular nurse epithelial cell). It was ve-
rified in vitro that NGF directly stimulates SNEC to increase the
levels of VEGF mRNA (Fig. 5A) and protein (Fig. 5B and C).
Furthermore, in vivo injection of NGF also caused an increaseof VEGF protein (Fig. 4c, f, and i) and elevated thymic blood
vessel (Fig. 4l) in regenerating thymus. These results indicate
that NGF promotes the production of thymic VEGF in vitro and
in vivo.
K252a, a well-known antagonist of TrkA [20], reduced the
level of NGF-induced VEGF mRNA in SNEC (Fig. 5D), sug-
gesting that NGF control of VEGF induction is via TrkA recep-
tor-mediated signaling pathways. In addition, considering that
cells immunolabeled for the TrkA and VEGF were identifiable
as thymic epithelial cells, the effect of NGF is probably
1471H.-J. Park et al. / Biochimica et Biophysica Acta 1773 (2007) 1462–1472attributable, at least in part, to autocrine release of VEGF in
thymic epithelial cells.
TECs, which provide MHC, antigen peptides, and growth
factors, play an essential role for intrathymic T-cell develop-
ment in thymus [28,44,45]. In addition, recent report demon-
strated that the ablation of VEGF gene in TECs alone was
sufficient to disrupt the network of thymic blood vessels [46],
suggesting the important role of TECs for providing instructive
cues for the correct spatial organization of the thymic vascu-
lature. Thus, it is likely that NGF-induced VEGF up-regulation
in TECs may produce concomitant angiogenesis in the rege-
nerating thymus.
In this study, we showed for the first time that reparative
angiogenesis occurs dramatically during adult thymic regenera-
tion that accompanies the up-regulation of VEGF gene expres-
sion. We also demonstrated that NGF induces thymic epithelial
expression of VEGF both in vitro and in vivo. In summary, our
results indicate that the reparative angiogenesis in the rege-
nerating thymus is probably attributable, at least in part, to the
NGF-mediated VEGF induction in thymic epithelial cells, sug-
gesting that modulators of VEGF and/or NGF signaling might
find usage as therapeutic regulators for the repair of acute, ac-
cidental, or age involution of adult thymus by stimulating
reparative angiogenesis.
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